Skip to content

Transthoracic Echocardiography in Assessing Patients With Suspected Endocarditis

Transthoracic Echocardiography in Assessing Patients With Suspected Endocarditis - Prospective Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07415369
Acronym
TEASE-Forward
Enrollment
350
Registered
2026-02-17
Start date
2026-03-01
Completion date
2027-04-01
Last updated
2026-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endocarditis Infective

Brief summary

This single-center, prospective observational study evaluates the accuracy of transthoracic echocardiography (TTE) to rule out infective endocarditis (IE) in patients with suspected IE, with the goal of reducing unnecessary transesophageal echocardiography (TOE), a more invasive diagnostic test. Eligible patients are those admitted to the Department of Cardiovascular Sciences at Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Rome, Italy) who undergo TOE for suspected IE within 15 days of a TTE. Clinical, laboratory, and echocardiographic variables will be collected to characterize the study population and support analyses of diagnostic performance and in-hospital outcomes.

Detailed description

Consecutive patients who undergo TOE for suspected infective endocarditis within 15 days after a TTE will be included. Patients whose diagnosis of endocarditis was established at another center will be excluded. For each participant, the study will collect demographics (age, sex, BMI), predisposing conditions (e.g., valvular prosthesis or intracardiac device, immunodeficiency, valvular heart disease), potentially modifiable risk factors (e.g., recent dental procedure or surgery, intravenous drug use), blood culture results, infections diagnosed at the time of TOE, clinical evidence of pulmonary and/or systemic embolization, blood tests, in-hospital mortality, and relevant comorbidities (e.g., chronic kidney failure, respiratory insufficiency, prior acute coronary syndrome or stroke, critical limb ischemia). These data will be used to describe the cohort and to explore how clinical context influences the ability of TTE to rule out IE. As a secondary endpoint, we will evaluate also the in-hospital outcomes of these patients.

Interventions

None listed

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age over 18 years; * patients who underwent transoesophageal echocardiography (TOE) for suspected infective endocarditis within 15 days of a transthoracic exam (TTE).

Exclusion criteria

\- diagnosis of endocarditis was made in another center.

Design outcomes

Primary

MeasureTime frameDescription
The primary endpoint of the study is the diagnosis of infective endocarditis during hospitalization.PeriproceduralThe purpose of our study was to evaluate the accuracy of TTE in ruling out IE in order to avoid unnecessary TOE, a more invasive and expensive diagnostic exam.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026